$FENC
FENNEC PHARMACEUTICALS INC.

2012 Q1 Form 10-Q Financial Statement

#000114420412028850 Filed on May 15, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $320.0K $710.0K
YoY Change -54.93% 255.0%
% of Gross Profit
Research & Development $296.0K $315.0K
YoY Change -6.03% 96.88%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $296.0K $315.0K
YoY Change -6.03% -14.86%
Operating Profit -$616.0K -$1.021M
YoY Change -39.67%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.331M $5.690M
YoY Change -41.46%
Pretax Income $2.720M $4.670M
YoY Change -41.76% -1362.16%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $2.715M $4.669M
YoY Change -41.85% -1361.89%
Net Earnings / Revenue
Basic Earnings Per Share $0.11 $0.23
Diluted Earnings Per Share $0.11 $0.19
COMMON SHARES
Basic Shares Outstanding 25.16M shares 20.57M shares
Diluted Shares Outstanding 25.16M shares 25.00M shares

Balance Sheet

Concept 2012 Q1 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.720M $5.020M
YoY Change -5.98% 1334.29%
Cash & Equivalents $4.719M $5.023M
Short-Term Investments
Other Short-Term Assets $14.00K $70.00K
YoY Change -80.0% -12.5%
Inventory
Prepaid Expenses $24.00K
Receivables $2.550M
Other Receivables $0.00
Total Short-Term Assets $4.760M $7.640M
YoY Change -37.7% 1525.53%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$3.000K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.760M $7.640M
Total Long-Term Assets -$3.000K $0.00
Total Assets $4.757M $7.640M
YoY Change -37.74% 1525.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $374.0K $440.0K
YoY Change -15.0% 29.41%
Accrued Expenses $38.00K $110.0K
YoY Change -65.45% 120.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.160M $7.920M
YoY Change -72.73% 1785.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.160M $7.920M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.162M $7.920M
YoY Change -72.7% 1741.86%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $104.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.595M -$290.0K
YoY Change
Total Liabilities & Shareholders Equity $4.757M $7.640M
YoY Change -37.74% 1525.53%

Cashflow Statement

Concept 2012 Q1 2011 Q1
OPERATING ACTIVITIES
Net Income $2.715M $4.669M
YoY Change -41.85% -1361.89%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$578.0K -$1.048M
YoY Change -44.85% 208.24%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change
Debt Paid & Issued, Net $0.00 $0.00
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -578.0K -1.048M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 0.000
Net Change In Cash -578.0K -1.048M
YoY Change -44.85% 208.24%
FREE CASH FLOW
Cash From Operating Activities -$578.0K -$1.048M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$578.0K -$1.048M
YoY Change -44.85% 208.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25157618 shares
CY1996Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY1996Q3 us-gaap Stockholders Equity
StockholdersEquity
0
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5023000
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1243000
CY2012Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1750000
CY2012Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38000
CY2012Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2012Q1 us-gaap Assets
Assets
4757000
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
65952000
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25158000 shares
CY2012Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
102665000
CY2012Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24000
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4719000
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4757000
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38065000
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
2595000
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25158000 shares
CY2012Q1 us-gaap Liabilities
Liabilities
2162000
CY2012Q1 us-gaap Other Assets Current
OtherAssetsCurrent
14000
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
374000
CY1997Q2 us-gaap Stockholders Equity
StockholdersEquity
-37000
CY1998Q2 us-gaap Stockholders Equity
StockholdersEquity
-435000
CY1999Q2 us-gaap Stockholders Equity
StockholdersEquity
242000
CY2000Q2 us-gaap Stockholders Equity
StockholdersEquity
47000
CY2001Q2 us-gaap Stockholders Equity
StockholdersEquity
9792000
CY2002Q2 us-gaap Stockholders Equity
StockholdersEquity
6071000
CY2003Q2 us-gaap Stockholders Equity
StockholdersEquity
698000
CY2004Q2 us-gaap Stockholders Equity
StockholdersEquity
20454000
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
16654000
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
11077000
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
1268000
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
14148000
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
3053000
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
406000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5947000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-4926000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1243000
CY2011Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5077000
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52000
CY2011Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2011Q4 us-gaap Assets
Assets
5351000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
65952000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25158000 shares
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
105380000
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5297000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5351000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38065000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-120000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25158000 shares
CY2011Q4 us-gaap Liabilities
Liabilities
5471000
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
19000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
342000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
1392000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
493000
us-gaap Net Income Loss
NetIncomeLoss
-6594000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1252000
us-gaap Net Income Loss
NetIncomeLoss
-37000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0
CY1998 us-gaap Net Income Loss
NetIncomeLoss
-398000
CY1999 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
20000
CY1999 us-gaap Net Income Loss
NetIncomeLoss
-958000
CY1999 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1615000
CY1999 adhxf Stock Issued During Period Value Exchange Of Owners Equity
StockIssuedDuringPeriodValueExchangeOfOwnersEquity
0
CY2001 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
182000
CY2001 us-gaap Net Income Loss
NetIncomeLoss
-2524000
CY2001 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
CY2002 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
11000
CY2002 us-gaap Net Income Loss
NetIncomeLoss
-3732000
CY2003 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-159000
CY2003 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-17795000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
209000
us-gaap Other Noncash Expense
OtherNoncashExpense
1187000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
87000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
8146000
CY2003 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1058000
CY2003 us-gaap Dividends Cash
DividendsCash
158000
CY2003 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
11620000
CY2003 adhxf Stated Capital Adjustment
StatedCapitalAdjustment
0
CY2005 us-gaap Stockholders Equity Other
StockholdersEquityOther
-141000
CY2005 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-13871000
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-16440000
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-13357000
CY2007 adhxf Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
694000
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-3012000
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-7824000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
4685000
CY2000 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
16000
CY2000 us-gaap Net Income Loss
NetIncomeLoss
-1605000
CY2000 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
793000
CY2000 adhxf Issuance Of Equity Rights
IssuanceOfEquityRights
171000
CY2004 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
18000
CY2004 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-219000
CY2004 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-6872000
CY2004 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1983000
CY2004 adhxf Stock Issued During Period Value Merger
StockIssuedDuringPeriodValueMerger
-22000
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-13600000
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2880000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
68000
us-gaap Gain On Derivative Instruments Pretax
GainOnDerivativeInstrumentsPretax
8147000
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
24000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
115000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1483000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
260000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
67389000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
22791000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
544000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
73000
us-gaap Revenues
Revenues
0
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
8000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-82621000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
896000
us-gaap Share Based Compensation
ShareBasedCompensation
10095000
us-gaap Interest Expense
InterestExpense
19000
CY2012Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
8000
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
65000
us-gaap Net Income Loss
NetIncomeLoss
-101256000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9985000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-36000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
386000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1440000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1404000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
465000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
640000
us-gaap Operating Income Loss
OperatingIncomeLoss
-111241000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
22148000
us-gaap Severance Costs
SeveranceCosts
168000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
86443000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3017000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4719000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
378000
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
35000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
166000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
13094000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30869000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
88445000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1283000
adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
190000
adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
412000
adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
497000
CY2011Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
10000
CY2011Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2011Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
CY2011Q1 us-gaap Gain On Derivative Instruments Pretax
GainOnDerivativeInstrumentsPretax
5680000
CY2011Q1 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0
CY2011Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2011Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2011Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2011Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
315000
CY2011Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
CY2011Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2011Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
47000
CY2011Q1 us-gaap Revenues
Revenues
0
CY2011Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1048000
CY2011Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2011Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2011Q1 us-gaap Interest Expense
InterestExpense
0
CY2011Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
CY2011Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
0
CY2011Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
CY2011Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
5680000
CY2011Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
4669000
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5690000
CY2011Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-10000
CY2011Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2011Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2011Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2011Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0
CY2011Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2011Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1021000
CY2011Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2011Q1 us-gaap Severance Costs
SeveranceCosts
0
CY2011Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2011Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-924000
CY2011Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20565000 shares
CY2011Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
124000
CY2011Q1 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0
CY2011Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2011Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
706000
CY2011Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25001000 shares
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2011Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2011Q1 adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0
CY2011Q1 adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0
CY2011Q1 adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Trading Symbol
TradingSymbol
ADHXF
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
ADHEREX TECHNOLOGIES INC
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001211583
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
CY2012Q1 us-gaap Gain On Derivative Instruments Pretax
GainOnDerivativeInstrumentsPretax
3327000
CY2012Q1 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0
CY2012Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2012Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
296000
CY2012Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
CY2012Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2012Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-34000
CY2012Q1 us-gaap Revenues
Revenues
0
CY2012Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-578000
CY2012Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2012Q1 us-gaap Interest Expense
InterestExpense
0
CY2012Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
CY2012Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
0
CY2012Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
CY2012Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3327000
CY2012Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
2715000
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3331000
CY2012Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0
CY2012Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2012Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-616000
CY2012Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2012Q1 us-gaap Severance Costs
SeveranceCosts
0
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2012Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-578000
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158000 shares
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0
CY2012Q1 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0
CY2012Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2012Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
320000
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25158000 shares
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2012Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2012Q1 adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0
CY2012Q1 adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0
CY2012Q1 adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0

Files In Submission

Name View Source Status
0001144204-12-028850-index-headers.html Edgar Link pending
0001144204-12-028850-index.html Edgar Link pending
0001144204-12-028850.txt Edgar Link pending
0001144204-12-028850-xbrl.zip Edgar Link pending
adhxf-20120331.xml Edgar Link completed
adhxf-20120331.xsd Edgar Link pending
adhxf-20120331_cal.xml Edgar Link unprocessable
adhxf-20120331_def.xml Edgar Link unprocessable
adhxf-20120331_lab.xml Edgar Link unprocessable
adhxf-20120331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
logo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v312766_10q.htm Edgar Link pending
v312766_ex31-1.htm Edgar Link pending
v312766_ex31-2.htm Edgar Link pending
v312766_ex32-1.htm Edgar Link pending
v312766_ex99-1.htm Edgar Link pending